Bryophyllum vs. Nifedipine

Weleda

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Tocolysis

Treatments: Drug: Bryophyllum p.

Study type: Interventional

Funder types: Industry

Identifiers

NCT00391339

CI-C-64-Wel-06

Details and patient eligibility

About

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female

Exclusion criteria

• Bishop Score > 5

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)